1. Home
  2. MED vs TLSA Comparison

MED vs TLSA Comparison

Compare MED & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MEDIFAST INC

MED

MEDIFAST INC

N/A

Current Price

$11.96

Market Cap

145.0M

ML Signal

N/A

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

N/A

Current Price

$0.68

Market Cap

145.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MED
TLSA
Founded
1980
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
145.0M
145.1M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
MED
TLSA
Price
$11.96
$0.68
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $7.87
AVG Volume (30 Days)
114.5K
★ 522.3K
Earning Date
10-26-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $934,842,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.22
$0.55
52 Week High
$13.63
$1.90

Technical Indicators

Market Signals
Indicator
MED
TLSA
Relative Strength Index (RSI) 42.88 46.12
Support Level $11.49 $0.57
Resistance Level $12.42 $1.21
Average True Range (ATR) 0.42 0.10
MACD -0.11 0.01
Stochastic Oscillator 4.17 55.24

Price Performance

Historical Comparison
MED
TLSA

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: